Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review

References

• CareyLAPerouCMLivasyCARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295212492250216757721
   PubMed Web of Science ®Google Scholar
• DentRTrudeauMPritchardKITriple-negative breast cancer: clinical features and patterns of recurrenceClin Cancer Res20071315 pt 14429443417671126
   PubMed Web of Science ®Google Scholar
• LakhaniSRVan De VijverMJJacquemierJThe pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2J Clin Oncol20022092310231811981002
   PubMed Web of Science ®Google Scholar
• MoranMSYangQHarrisLNJonesBTuckDPHafftyBGLong-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancerCancer200811392565257418816610
   PubMedGoogle Scholar
• Bonsang-KitzisHChaltierLBelinLBeyond axillary lymph node metastasis, BMI and menopausal status are prognostic determinants for triple-negative breast cancer treated by neoadjuvant chemotherapyPLoS One20151012e014435926684197
   PubMedGoogle Scholar
• NielsenTOHsuFDJensenKImmunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaClin Cancer Res200410165367537415328174
   PubMed Web of Science ®Google Scholar
• SotiriouCNeoSYMcShaneLMBreast cancer classification and prognosis based on gene expression profiles from a population-based studyProc Natl Acad Sci U S A200310018103931039812917485
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)DarbySMcGalePEffect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trialsLancet201137898041707171622019144
   PubMed Web of Science ®Google Scholar
• EiermannWVallisKALocoregional treatments for triple-negative breast cancerAnn Oncol201223suppl 6vi30vi3423012299
   PubMedGoogle Scholar
• BryanBBSchnittSJCollinsLCDuctal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancerMod Pathol20061961762116528377
   PubMedGoogle Scholar
• FoulkesWDSmithIEReis-FilhoJSTriple-negative breast cancerN Engl J Med2010363201938194821067385
   PubMed Web of Science ®Google Scholar
• PignolJPRakovitchEOlivottoIAIs breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?J Clin Oncol201129212841284321670459
   PubMedGoogle Scholar
• AebiSDavidsonTGruberGCardosoFPrimary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201122suppl 6vi12vi2421908498
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN)Clinical Practice Guidelines in Oncology: Breast Cancer v22016 Available from: https://www.nccn.org/patients/guidelines/stage_i_ii_breast/index.htmlAccessed July 15, 2016
   Google Scholar
• CoatesASWinerEPGoldhirschATailoring therapies – improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Ann Oncol20152681533154625939896
   PubMed Web of Science ®Google Scholar
• RechtAEdgeSBSolinLJAmerican Society of Clinical OncologyPostmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyJ Clin Oncol20011951539156911230499
   PubMed Web of Science ®Google Scholar
• TaylorMEHafftyBGRabinovitchRACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breastInt J Radiat Oncol Biol Phys2009734997100219251087
   PubMedGoogle Scholar
• HarnettASmallwoodJTitshallVChampionADiagnosis and treatment of early breast cancer, including locally advanced disease – summary of NICE guidanceBMJ2009338b43819244302
   PubMedGoogle Scholar
• Sautter-BihlMLSouchonRBudachWDEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced diseaseStrahlenther Onkol2008184734735319016032
   PubMedGoogle Scholar
• EBCTCG (Early Breast Cancer Trialists’ Collaborative Group)McGalePTaylorCEffect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8,135 women in 22 randomised trialsLancet201438399352127213524656685
   PubMed Web of Science ®Google Scholar
• SauerRSchulzKDHellriegelKPStrahlentherapie nach Mastektomie – Interdisziplinärer Konsensus beendet Kontroverse [Radiation therapy after mastectomy – interdisciplinary consensus puts and end to a controversy. German Society of Senology]Strahlenther Onkol2001177119
   PubMedGoogle Scholar
• HojrisIOvergaardMChristensenJJOvergaardJMorbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative GroupLancet199935491881425143010543669
   PubMed Web of Science ®Google Scholar
• Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet200035592171757177010832826
   PubMed Web of Science ®Google Scholar
• OvergaardMNielsenHMOvergaardJIs the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trialsRadiother Oncol200782324725317306393
   PubMed Web of Science ®Google Scholar
• LiYMoranMSHuoQYangQHafftyBGPost-mastectomy radiotherapy for breast cancer patients with t1–t2 and 1–3 positive lymph nodes: a meta-analysisPLoS One2013812e8176524312582
   PubMedGoogle Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• RakhaEAReis-FilhoJSEllisIOBasal-like breast cancer: a critical reviewJ Clin Oncol200826152568258118487574
   PubMed Web of Science ®Google Scholar
• WeigeltBBaehnerFLReis-FilhoJSThe contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decadeJ Pathol2010220226328019927298
   PubMed Web of Science ®Google Scholar
• SotiriouCPusztaiLGene-expression signatures in breast cancerN Engl J Med2009360879080019228622
   PubMed Web of Science ®Google Scholar
• KreikeBvan KouwenhoveMHorlingsHGene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomasBreast Cancer Res200795R6517910759
   PubMed Web of Science ®Google Scholar
• Reis-FilhoJSTuttANTriple negative tumours: a critical reviewHistopathology200852110811818171422
   PubMed Web of Science ®Google Scholar
• LoweryAJKellMRGlynnRWKerinMJSweeneyKJLocoregional recurrence after breast cancer surgery: a systematic review by receptor phenotypeBreast Cancer Res Treat2012133383184122147079
   PubMed Web of Science ®Google Scholar
• BillarJADueckACStuckyCCTriple-negative breast cancers: unique clinical presentations and outcomesAnn Surg Oncol201017suppl 338439020853062
   PubMedGoogle Scholar
• AbdulkarimBSCuarteroJHansonJDeschênesJLesniakDSabriSIncreased risk of locoregional recurrence for women with T1–2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapyJ Clin Oncol201129212852285821670451
   PubMedGoogle Scholar
• WangJXieXWangXLocoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysisSurg Oncol201322424725524144808
   PubMedGoogle Scholar
• ZumstegZSMorrowMArnoldBBreast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1–2N0 triple-negative breast cancerAnn Surg Oncol201320113469347623686101
   PubMed Web of Science ®Google Scholar
• Bhoo-PathyNVerkooijenHMWongFYPrognostic role of adjuvant radiotherapy in triple-negative breast cancer: a historical cohort studyInt J Cancer2015137102504251226018878
   PubMedGoogle Scholar
• LyBKwonDReisIComparison of clinical outcomes in early stage triple negative breast cancer treated with mastectomy versus breast conserving therapyInt J Radiat Oncol Biol Phys201284S258S259
   Google Scholar
• van MaarenMCde MunckLde BockGH10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based studyLancet Oncol20161781158117027344114
   PubMed Web of Science ®Google Scholar
• ChenXYuXChenJRadiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1–T2 disease and one to three positive lymph nodes after mastectomyOncologist201318214114723335622
   PubMedGoogle Scholar
• KongMHongSEWhich patients might benefit from postmastectomy radiotherapy in breast cancer patients with t1–2 tumor and 1–3 axillary lymph nodes metastasis?Cancer Res Treat201345210311123864843
   PubMedGoogle Scholar
• GabosZThomsJGhoshSThe association between biological subtype and locoregional recurrence in newly diagnosed breast cancerBreast Cancer Res Treat2010124118719420814819
   PubMed Web of Science ®Google Scholar
• WangJShiMLingRAdjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trialRadiother Oncol2011100220020421852010
   PubMedGoogle Scholar
• JagsiRRaadRAGoldbergSLocoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiationInt J Radiat Oncol Biol Phys20056241035103915990006
   PubMed Web of Science ®Google Scholar
• TruongPTLesperanceMCulhaciAKaderHASpeersCHOlivottoIAPatient subsets with T1–T2, node-negative breast cancer at high locoregional recurrence risk after mastectomyInt J Radiat Oncol Biol Phys200562117518215850919
   PubMedGoogle Scholar
• ShenHZhaoLWangLPostmastectomy radiotherapy benefit in Chinese breast cancer patients with T1–T2 tumor and 1–3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 casesTumour Biol20163756465647526631044
   PubMedGoogle Scholar
• ChenXYuXChenJAnalysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factorsCancer2013119132366237423576181
   PubMed Web of Science ®Google Scholar
• TrovoMDurofilEPoleselJLocoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?Int J Radiat Oncol Biol Phys2012832e153e15722386375
   PubMed Web of Science ®Google Scholar
• TruongPTOlivottoIAKaderHAPanadesMSpeersCHBertheletESelecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapyInt J Radiat Oncol Biol Phys20056151337134715817335
   PubMed Web of Science ®Google Scholar
• HouvenaeghelGSabatierRReyalFAxillary lymph node micrometastases decrease triple-negative early breast cancer survivalBr J Cancer201611591024103127685443
   PubMed Web of Science ®Google Scholar
• EdgeSByrdDRComptonCCFritzAGGreeneFLTrottiAAJCC Cancer Staging Manual7th edNew YorkSpringer2010
   Google Scholar
• AtchleyDPAlbarracinCTLopezAClinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancerJ Clin Oncol200826264282428818779615
   PubMed Web of Science ®Google Scholar
• YehielyFMoyanoJVEvansJRNielsenTOCrynsVLDeconstructing the molecular portrait of basal-like breast cancerTrends Mol Med2006121153754417011236
   PubMed Web of Science ®Google Scholar
• PierceLJPhillipsKAGriffithKALocal therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyBreast Cancer Res Treat2010121238939820411323
   PubMed Web of Science ®Google Scholar
• RobsonMEBradburyARArunBAmerican Society of Clinical Oncology Policy Statement Update: genetic and genomic testing for cancer susceptibilityJ Clin Oncol201533313660366726324357
   PubMed Web of Science ®Google Scholar
• ScullyRLivingstonDMIn search of the tumour-suppressor functions of BRCA1 and BRCA2Nature2000408681142943211100717
   PubMed Web of Science ®Google Scholar
• MoranMSRadiation therapy in the locoregional treatment of triple-negative breast cancerLancet Oncol2015163e113e12225752562
   PubMedGoogle Scholar
• KyndiMSørensenFBKnudsenHDanish Breast Cancer Cooperative GroupEstrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative GroupJ Clin Oncol20082691419142618285604
   PubMed Web of Science ®Google Scholar
• BaeyensAThierensHClaesKPoppeBde RidderLVralAChromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriersInt J Radiat Biol2004801074575615799620
   PubMed Web of Science ®Google Scholar
• TrenzKLugowskiSJahrsdörferUJaintaSVogelWSpeitGEnhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostaticsMutat Res20035442–327928814644329
   PubMedGoogle Scholar
• LehmannBDBauerJAChenXIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJ Clin Invest201112172750276721633166
   PubMed Web of Science ®Google Scholar
• NishimuraRArimaNIs triple negative a prognostic factor in breast cancer?Breast Cancer200815430330818369692
   PubMedGoogle Scholar
• BauerKRBrownMCressRDPariseCACaggianoVDescriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer RegistryCancer200710991721172817387718
   PubMed Web of Science ®Google Scholar